Cargando…
Dexamethasone-Mediated Upregulation of Calreticulin Inhibits Primary Human Glioblastoma Dispersal Ex Vivo
Dispersal of Glioblastoma (GBM) renders localized therapy ineffective and is a major cause of recurrence. Previous studies have demonstrated that Dexamethasone (Dex), a drug currently used to treat brain tumor–related edema, can also significantly reduce dispersal of human primary GBM cells from neu...
Autores principales: | Nair, Mohan, Romero, Juan, Mahtabfar, Aria, Meleis, Ahmed M., Foty, Ramsey A., Corbett, Siobhan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855794/ https://www.ncbi.nlm.nih.gov/pubmed/29443896 http://dx.doi.org/10.3390/ijms19020572 |
Ejemplares similares
-
Dexamethasone-mediated inhibition of Glioblastoma neurosphere dispersal in an ex vivo organotypic neural assay
por: Meleis, Ahmed M., et al.
Publicado: (2017) -
Teaching an Old Drug New Tricks: Dexamethasone as an In Vivo Inhibitor of Glioblastoma Dispersal
por: Carminucci, Arthur, et al.
Publicado: (2020) -
Dexamethasone-Mediated Activation of Fibronectin Matrix Assembly Reduces Dispersal of Primary Human Glioblastoma Cells
por: Shannon, Stephen, et al.
Publicado: (2015) -
Inhibition of glioblastoma dispersal by the MEK inhibitor PD0325901
por: Shannon, Stephen, et al.
Publicado: (2017) -
Fibronectin Matrix Assembly Suppresses Dispersal of Glioblastoma Cells
por: Sabari, Joshua, et al.
Publicado: (2011)